T. Clark Gamblin, MD, MS, MBA

Professor and Chief, Surgical Oncology; Stuart D. Wilson Professor of Surgery; Vice Chair, Off-Campus Clinical Operations

view physician profile

Locations

Froedtert Hospital
Froedtert Menomonee Falls Hospital
Froedtert West Bend Hospital
Zablocki VA Medical Center
Cancer Center - Froedtert Hospital

Specialties

Surgical Oncology
General Surgery

Languages

English

Contact Information

Education

MD - Doctor of Medicine
MS -Master of Science
MBA - Master of Business Administration

Biography

T. Clark Gamblin, MD, MS, MBA, The Stuart D. Wilson Chair in Surgical Oncology is the Chief of Surgical Oncology and the Vice Chair for Off-Campus Clinical Operations for the Medical College of Wisconsin. Dr. Gamblin joined The Medical College of Wisconsin in 2010 from the University of Pittsburgh School of Medicine. Dr. Gamblin’s practice is focused on hepatobiliary cancer and other gastrointestinal malignancies.

Dr. Gamblin serves on the editorial board for the Annals of Surgery, Annals of Surgical Oncology, and the Journal of Surgical Oncology. He holds memberships in numerous professional and scientific societies including the American Surgical Association and the Society of Clinical Surgery. Dr. Gamblin has more than 225 peer reviewed publications and has authored multiple reviews and book chapters in addition to editing 3 books. He has presented more than 100 lectures on the multimodality management of liver tumors to regional, national and international audiences.

                
                    Research Experience
                
                    Carcinoma, Hepatocellular
Liver
Liver Diseases
Liver Neoplasms

                    Clinical Expertise
                
                    Advanced abdominal malignancies
Bile Ducts
Carcinoma, Hepatocellular
Digestive System Diseases
Gallbladder
General Surgery
Hepatectomy
Infusion Pumps, Implantable
Liver Neoplasms

                    Methodologies and Techniques
                
                    Comparative Study
Multicenter Studies as Topic
Outcome Assessment (Health Care)
Practice Guideline
Therapies, Investigational
Xenograft Model Antitumor Assays

                    Leadership Positions
                
                    Chief, Division of Surgical Oncology
Co-Director of HPB Surgery Clinical Fellowship
Director of HPB Surgery Research Fellowship
HPB Clinical Program Leader
HPB Faculty Research Leader
Vice Chair, Off-Campus Clinical Operations

Research Interests

Dr. Gamblin’s research interests include utilizing large dataset to optimize management and outcomes of hepatobiliary patients. He has led multiple research efforts including clinical trials on the treatment of hepatocellular carcinoma and cholangiocarcinoma.

Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis.

(Chouliaras K, Patel N, Senehi R, Ethun CG, Poultsides G, Grignol V, Gamblin TC, Roggin KK, Fields RC, D'Agostino R Jr, Levine EA, Cardona K, Votanopoulos K.) J Surg Oncol. 2021 Feb;123(2):479-488 PMID: 33150594 SCOPUS ID: 2-s2.0-85096639117 11/06/2020
Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis

(Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D’Angelica MI, Aloia TA, Eastwood D, Gamblin TC.) Annals of Surgical Oncology. 2021 SCOPUS ID: 2-s2.0-85098739759 01/01/2021
High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma.

(Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN.) Surgery. 2020 10;168(4):760-767 PMID: 32736869 SCOPUS ID: 2-s2.0-85088789886 08/02/2020
A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative.

(Lee RM, Ethun CG, Zaidi MY, Tran TB, Poultsides GA, Grignol VP, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Oskouei SV, Monson DK, Reimer NB, Maithel SK, Cardona K.) Surg Oncol. 2020 Sep;34:292-297 PMID: 32891345 SCOPUS ID: 2-s2.0-85087369172 09/07/2020
Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base.

(Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC.) J Surg Oncol. 2020 Aug;122(2):176-182 PMID: 32383268 SCOPUS ID: 2-s2.0-85085151262 05/10/2020
The Chicago Consensus on Peritoneal Surface Malignancies: Standards.

(Chicago Consensus Working Group.) Ann Surg Oncol. 2020 Jun;27(6):1743-1752 PMID: 32285276 SCOPUS ID: 2-s2.0-85083312765 04/15/2020
The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations.

(Chicago Consensus Working Group.) Ann Surg Oncol. 2020 Jun;27(6):1798-1804 PMID: 32285272 SCOPUS ID: 2-s2.0-85083343126 04/15/2020
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms.

(Chicago Consensus Working Group.) Ann Surg Oncol. 2020 Jun;27(6):1780-1787 PMID: 32285271 SCOPUS ID: 2-s2.0-85083287875 04/15/2020
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases.

(Chicago Consensus Working Group.) Ann Surg Oncol. 2020 Jun;27(6):1768-1773 PMID: 32285269 SCOPUS ID: 2-s2.0-85083329258 04/15/2020
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors.

(Chicago Consensus Working Group.) Ann Surg Oncol. 2020 Jun;27(6):1793-1797 PMID: 32285268 SCOPUS ID: 2-s2.0-85083346862 04/15/2020
The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms.

(Chicago Consensus Working Group.) Cancer. 2020 06 01;126(11):2525-2533 PMID: 32282073 SCOPUS ID: 2-s2.0-85084594927 04/14/2020
A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative

(Lee RM, Ethun CG, Zaidi MY, Tran TB, Poultsides GA, Grignol VP, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Oskouei SV, Monson DK, Reimer NB, Maithel SK, Cardona K.) Surgical Oncology. September 2020;34:292-297 SCOPUS ID: 2-s2.0-85087369172 09/01/2020